Groupe sante CHC - Clinique du MontLegia

Liège 4000

2 studies enrolling now · 2 studies all time

What they study most

Ovarian Cancer, Type 1 Diabetes

Studies at this site

• SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now